LEADER 03069nam  2200601Ia 450 
001 9910146118803321
005 20230721005328.0
010   $a1-282-00755-6
010   $a9786612007552
010   $a1-4443-0335-X
010   $a1-4443-0336-8
035   $a(CKB)1000000000722795
035   $a(EBL)416378
035   $a(OCoLC)476247612
035   $a(SSID)ssj0000117872
035   $a(PQKBManifestationID)11141950
035   $a(PQKBTitleCode)TC0000117872
035   $a(PQKBWorkID)10049462
035   $a(PQKB)11779029
035   $a(MiAaPQ)EBC416378
035   $a(Au-PeEL)EBL416378
035   $a(CaPaEBR)ebr10300979
035   $a(CaONFJC)MIL200755
035   $a(EXLCZ)991000000000722795
100   $a20080612d2008      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aCardiovascular risk management$b[electronic resource] /$fedited by F.D. Richard Hobbs, Bruce Arroll
210   $aChichester, West Sussex, UK ;$aHoboken, NJ $cWiley-Blackwell$d2008, c2009
215   $a1 online resource (100 p.)
300   $aDescription based upon print version of record.
311   $a1-4051-5575-2 
320   $aIncludes bibliographical references and index.
327   $aContents; Foreword; Contributors; 1. The epidemiology of cardiovascular disease; 2. Using guidelines as a framework for cardiovascular risk management: comparison of international recommendations; 3. Identifying high-risk patients; 4. Moderate- to low-risk patients: management recommendations; 5. High-risk patients: management recommendations; 6. Type 2 diabetes and metabolic syndrome patients: management recommendations for reducing cardiovascular risk; 7. Lifestyle changes to reduce cardiovascular risk; 8. Pharmacotherapy: improving the lipid profile
327   $a9. Pharmacotherapy: lowering blood pressure10. Pharmacotherapy: lowering blood glucose; 11. Long-term management of cardiovascular disease; 12. Managing cardiovascular risk in the future; Appendix; Index; A; B; C; D; E; F; G; H; I; J; L; M; N; O; P; R; S; T; U; V; W
330   $aPractical ABC styleEnables doctors to prioritise treatment using risk-scoring systems and holistic recommendations for reducing cardiovascular riskIncludes treatment plans for individuals with diabetes, who are at high risk of developing cardiovascular diseaseHow to reduce cardiovascular risk in other specific patient groupsDeveloped by expert groups in different regions of the world
606   $aCardiovascular system$xDiseases$xRisk factors
606   $aCardiovascular system$xDiseases$xPrevention
615  0$aCardiovascular system$xDiseases$xRisk factors.
615  0$aCardiovascular system$xDiseases$xPrevention.
676   $a616.105
701   $aHobbs$b Richard$cM.R.C.G.P.$0217497
701   $aArroll$b Bruce$0864982
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910146118803321
996   $aCardiovascular risk management$91930549
997   $aUNINA